Daniel Austin, DO
Family Medicine · Pittsburgh, PANPI 1407274699
Payments from drug & device makers
Across 301 payments — averaging $1985.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$404K
- Sanofi Pasteur Inc.$60K
- Pfizer$58K
- Boehringer Ingelheim$42K
- Boehringer Ingelheim Pharma GmbH & Co.kg$15K
- Kowa Research Institute, Inc.$13K
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 21 | $404,203 |
| Sanofi Pasteur Inc. | 19 | $60,438 |
| Pfizer | 30 | $58,183 |
| Boehringer Ingelheim | 12 | $41,917 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 5 | $15,023 |
| Kowa Research Institute, Inc. | 1 | $13,344 |
| Boehringer Ingelheim International GmbH | 12 | $1,327 |
| Novo Nordisk | 29 | $480 |
| GSK | 29 | $395 |
| AbbVie | 19 | $354 |
| AstraZeneca | 18 | $312 |
| Johnson & Johnson | 18 | $244 |
| Amgen | 12 | $204 |
| Lilly USA, LLC | 13 | $181 |
| Sanofi-aventis U.S. LLC | 12 | $143 |
| Merck | 11 | $131 |
| Astellas Pharma US Inc | 6 | $105 |
| Biohaven Pharmaceuticals, Inc. | 7 | $103 |
| Amarin Pharma, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 2 | $62 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Urovant Sciences Inc | 2 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $39 |
| Novartis | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Acorda Therapeutics, Inc | 1 | $16 |
How this compares
$597,577 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Pittsburgh
- Bryce PalchickPittsburgh$4.7M
- Shari RozenPittsburgh$2.9M
- Nathan BennettPittsburgh$1.6M
- James MorettiPittsburgh$1.5M
- Michael GatesPittsburgh$608K
- Norman KolbPittsburgh$81K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Harris CohenHorsham$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.